Akoustis Technologies Inc (AKTS) Stock Price, Quote & News

Company Profile

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a rad...

Industry: Biotechnology

Sector: Healthcare

Phone: 617-461-4023

Website: www.aktisoncology.com

Address:

17 Drydock Avenue, Suite 17-401, Boston, United States

RadioIsotope25 Feb. 16 at 6:17 PM

Theranostics earmarked as “the future” of radiopharmaceuticals - Pharmaceutical Technology $RADX $CATX $AKTS $LLY https://www.pharmaceutical-technology.com/features/theranostic-radiopharmaceuticals-future-of-radiopharma/

0 · Reply

RadioIsotope25 Feb. 13 at 3:33 PM

Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CHRS $PYXS https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/

0 · Reply

Gator5326 Feb. 13 at 1:24 AM

$AKTS Feb 18 could be a good day

0 · Reply

RadioIsotope25 Feb. 13 at 1:14 AM

$RADX $CATX $AKTS

1 · Reply

RadioIsotope25 Feb. 11 at 3:20 PM

This news might crash $AKTS and make $RADX rally. RADX is all beta emitters and Aktis all actinium. $CATX plus Radiopharm is in bed with Lantheus Lilly misses its Point | ApexOnco - Clinical Trials news and analysis https://www.oncologypipeline.com/apexonco/lilly-misses-its-point

1 · Reply

CapitalHarbor Feb. 4 at 2:27 PM

$AKTS is a provider of electronics design and test software; it operates in a niche market with stable demand but limited growth potential.

1 · Reply

RadioIsotope25 Feb. 3 at 2:56 PM

Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX

1 · Reply

RadioIsotope25 Feb. 3 at 1:01 AM

$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX

0 · Reply

RadioIsotope25 Feb. 2 at 3:21 PM

Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CATX https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/

0 · Reply

RadioIsotope25 Feb. 2 at 2:49 PM

$RADX CATX just raised $179 million this morning. Radiopharm is simmering $CATX $AKTS

0 · Reply

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jan 9, 2026, 10:05 PM EST - 5 weeks ago

U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO

Jan 9, 2026, 12:58 PM EST - 5 weeks ago

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

LLY

Jan 8, 2026, 9:20 PM EST - 5 weeks ago

Aktis Oncology prices upsized US IPO at $18 per share

Jan 8, 2026, 8:48 PM EST - 5 weeks ago

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Jan 6, 2026, 11:50 AM EST - 5 weeks ago

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

Jan 2, 2026, 10:35 PM EST - 6 weeks ago

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

APC BTGO EQPT GRAY IBL KLK ATYR

Dec 19, 2025, 5:51 PM EST - 2 months ago

Aktis Oncology files for US IPO as biotech listings rebound

Dec 19, 2025, 5:51 PM EST - 2 months ago

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Dec 19, 2025, 4:02 PM EST - 2 months ago

Aktis Oncology IPO Registration Document (S-1)

RadioIsotope25 Feb. 16 at 6:17 PM

0 · Reply

RadioIsotope25 Feb. 13 at 3:33 PM

0 · Reply

Gator5326 Feb. 13 at 1:24 AM

$AKTS Feb 18 could be a good day

0 · Reply

RadioIsotope25 Feb. 13 at 1:14 AM

$RADX $CATX $AKTS

1 · Reply

RadioIsotope25 Feb. 11 at 3:20 PM

1 · Reply

CapitalHarbor Feb. 4 at 2:27 PM

$AKTS is a provider of electronics design and test software; it operates in a niche market with stable demand but limited growth potential.

1 · Reply

RadioIsotope25 Feb. 3 at 2:56 PM

Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX

1 · Reply

RadioIsotope25 Feb. 3 at 1:01 AM

$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX

0 · Reply

RadioIsotope25 Feb. 2 at 3:21 PM

0 · Reply

RadioIsotope25 Feb. 2 at 2:49 PM

$RADX CATX just raised $179 million this morning. Radiopharm is simmering $CATX $AKTS

0 · Reply

Billonstart Jan. 30 at 8:14 PM

$AKTS We need patience to make money.

0 · Reply

RadioIsotope25 Jan. 29 at 11:43 PM

$RADX $AKTS https://youtu.be/AAoayfujeFs

0 · Reply

RadioIsotope25 Jan. 28 at 3:21 PM

$RADX Upside in Aktis is $4 billion equals 300%. Their market cap is $1 billion already they have the halo ipo valuation. Upside in Radiopharm Theranostics is minimum $200-500 million could be $1 to 2 billion. At $60 million market cap you calculate the upside. $AKTS $LNTH

0 · Reply

RadioIsotope25 Jan. 28 at 2:45 AM

RADX vs AKTS $60 million vs $1 billion $RADX $AKTS

3 · Reply

RadioIsotope25 Jan. 27 at 2:58 PM

Alpha- vs Beta-Radiopharmaceuticals Impact Immune Checkpoints Differently $AKTS $RADX $CATX https://bioengineer.org/alpha-vs-beta-radiopharmaceuticals-impact-immune-checkpoints-differently/

0 · Reply

RadioIsotope25 Jan. 26 at 10:50 PM

$AKTS Nice reversal today

0 · Reply

Billonstart Jan. 26 at 6:13 AM

$AKTS It is Great company. It will go to the moon.

0 · Reply

RadioIsotope25 Jan. 23 at 11:37 PM

Radiopharmaceuticals are on the rise as drug developers realize enormous potential | TRACER $RADX $AKTS https://www.tracercro.com/resources/blogs/radiopharmaceuticals-are-on-the-rise-as-drug-developers-realize-enormous-potential/

0 · Reply

Love_To_Learn Jan. 23 at 12:27 PM

$AKTS sorry was for $AKTX **************

0 · Reply

Love_To_Learn Jan. 23 at 12:26 PM

$AKTS need to make a change to u * creating issues for the other stocksso will move u out the way

0 · Reply

RadioIsotope25 Jan. 22 at 8:37 PM

$AKTS $RADX $CATX

0 · Reply

cor1 Jan. 22 at 6:11 PM

$RADX $AKTS

0 · Reply

Market Cap	5.75M
Revenue (ttm)	27.38M
Net Income (ttm)	-167.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-613.40%
Debt to Equity Ratio	0.00

Volume	118,703,398
Avg Vol	26,170,799
Day's Range	N/A - N/A
Shares Out	154.59M
Stochastic %K	6%
Beta	1.91
Analysts	Sell
Price Target	$1.00